Comparing vaccine incentives in the US and Europe

Comparing vaccine incentives in the US and Europe

Source: 
Biopharma Dive
snippet: 

High development costs and risk of failure, as well as once- or twice-in-a-lifetime use, are just some of the hurdles depressing incentives for drugmakers to develop vaccines.